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Abstract: A randomized controlled efficacy trial targeting older adults with hypertension is 
providing a tailored education intervention with a Next Generation Personal Education Program 
(PEP-NG) in primary care practices in New England. Ten participating advanced practice 
registered nurses (APRNs) completed online knowledge and self-efficacy measures pre-onsite 
training and twice more after completing a continuing education program. Patient participants 
self-refer in response to study recruitment brochures and posters. Twenty-four participants 
from each APRN practice (total N = 240) are randomly assigned by the PEP-NG software to 
either control (data collection and four routine APRN visits) or tailored intervention (PEP-NG 
interface and four focused APRN visits) conditions. Patients access the PEP-NG interface via 
wireless tablet and use a stylus to answer demographic, knowledge, and self-efficacy questions 
as well as prescription and over-the-counter self-medication practice questions. The PEP-NG 
analyzes patient-reported information and delivers tailored educational content. Patients’ 
outcome measures are self-reported antihypertensive medication adherence, blood pressure, 
knowledge and self-efficacy concerning potential adverse self-medication practices, adverse 
self-medication behavior “risk” score and satisfaction with the PEP-NG and APRN provider 
relationship. APRN outcome measures are knowledge and self-efficacy concerning adverse 
self-medication practices, self-efficacy for communicating with older adults and satisfaction 
with the PEP-NG. Time–motion and cost–benefit analyses will be conducted.
Keywords: hypertension, self-medication, older adults, tailored intervention, computer-based 
education
Introduction
Despite frequent primary care visits, adults over the age of 60 years often do not achieve 
target blood pressure (BP) readings (140/90; 130/80 for those with diabetes or 
chronic kidney disease).1–5 An estimated $100 billion is spent annually in the United 
States on health care for patients with poorly controlled BP in part due to poor 
antihypertensive medication adherence and other adverse self-medication behaviors.6–10 
Failure of the health care system to identify and remediate poor adherence and adverse 
self-medication behaviors adds to the overall cost of treatment as providers typically 
intensify antihypertensive therapy and add additional agents to the regimen which 
further increases the risk of adverse drug side effects as well as cost.11,12
Recent trials aimed at improving patient adherence to antihypertensive therapy 
have yet to demonstrate large long-term improvements in either adherence or health Patient Preference and Adherence 2009:3 324
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outcomes.13 Intensive and frequent (monthly) counseling can 
greatly improve antihypertensive adherence, but adherence 
declines to baseline when the intervention is removed.14–16 
Patient adherence to antihypertensives has been shown to be 
greatest five days prior and five days after health care visit 
and usually declines within 30 days to typify the so called 
“white coat adherence.”7
Inadequate patient education about adherence and safe 
medication use contributes to preventable adverse drug events.6 
Over-the-counter (OTC) medications, supplements, and alcohol 
can interact with antihypertensives and contribute to poor BP 
control.6,10,17 For example, nonsteroidal anti-inflammatory drugs 
(NSAIDS such as ibuprofen) increase BP and antagonize the 
efficacy of antihypertensives and the anti-platelet effects of low-
dose aspirin when taken concurrently.18–20 Many patients choose 
inappropriate OTC analgesics such as NSAIDs to self-medicate 
pain.21,22 In separate surveys of English- and Spanish-speaking 
older adults with hypertension, more than 85% reported two 
or more adverse self-medication practices.21,22 Older adults 
with hypertension also had large knowledge deficits regarding 
conflicts between prescription and OTC agents, as well as low 
confidence in their ability to avoid these conflicts.23 Addressing 
adverse self-medication practices is one step toward reducing 
the risk of potential adverse drug interactions (PADI).
A personal computer (PC)-based interactive Personal 
Education Program (PEP) was effective in improving 
knowledge and self-efficacy in addition to reducing adverse 
self-medication practices in older adults with hypertension.24,25 
The PEP was upgraded to the “next generation” PEP (PEP-NG), 
a web-based program accessed wirelessly. The PEP-NG has the 
following attributes: 1) embedded measurement instruments 
to capture demographics, medication use, knowledge 
and self-efficacy about avoiding adverse self-medication 
behaviors, and satisfaction with the provider relationship and 
system-interface, and 2) a rules engine that analyzes patient 
reported information as the basis for delivering a tailored 
educational intervention to the individual patient.
This paper details the design and methods of a clinical 
trial testing the effectiveness of the PEP-NG in primary 
care practices. Specifically designed to increase medication 
adherence and reduce adverse self-medication behaviors 
in older patients with hypertension, this web-based 
intervention/education system is the first of its kind.
Trial design and methods
Overview
The PEP-NG profiles and analyzes patient risk levels 
by capturing individual self-medication behaviors and 
related knowledge and self-efficacy. Patients access the 
PEP-NG interface via a wireless tablet PCa and use a stylus 
to interact with a set of medication regimen (prescription and 
over-the-counter) and self-medication practice questions. The 
PEP-NG analyzes patient-entered information and delivers 
tailored educational content. A rules engine selects and 
addresses three adverse self-medication behaviors (with the 
highest risk scores) and offers the following: 1) “medicine 
facts;” 2) animations that illustrate the consequences of the 
adverse behaviors identified; 3) “what you can do” correc-
tive strategies; and 4) realistic scenarios that allow the user 
to practice the information learned.
The PEP-NG prints summaries for both the patient and 
provider of patient-reported symptoms, medication use 
(including frequency/time), adverse self-medication behaviors 
(along with a thumbnail illustration) and corrective strategies. 
Prior to the patient-provider visit, providers enter the pre-
scribed medication regimen and patient’s blood pressure, age, 
and health literacy scores on a separate provider interface 
on the PEP-NG. This allows the provider to review and contrast 
the provider-entered data against the patient printout prior to 
the primary care visit. The printout also supports the provider 
in reinforcing guidance and oversight of adherence behaviors. 
The patient takes a copy of the printout home for self-study.
Trial data collected are automatically transferred to a 
Microsoft Access database (Microsoft Corp., Redmond, WA) 
via Virtual-Private-Network, which meets or exceeds the 
HIPAA requirements26 and the European Union Directive 
95/46/EC.27 The interface was developed in accordance with 
ISO 9100 international standards.28,29
The PEP-NG was designed through formative research 
and formal usability studies with advanced practice regis-
tered nurse (APRN) providers and older adults.30–33 The text, 
graphic elements and animation materials are programmed 
with Macromedia’s Flash ActionScript language (Adobe, 
San Jose, CA). Objects are large (3 cm high) and text is in a 
20-point Arial Black font. The text and background colors, 
illumination level, and the graphic and animation style and 
speed meet the visual and cognitive processing capabilities 
of older adults.30 Wide scroll bars and dropdown-menus 
displayed in blocks of eight lines ease use for those with 
impaired hand mobility and/or fine tremor. An animated 
aThe tablet PC (Motion LE 1600 Centrino) was manufactured by the Motion 
Computing, Inc. in 2006. Technical specifications for this model include: Intel 
Pentium® M Processor LV 778 (1.6 GHz), Integrated Intel PRO Wireless 
2915ABG, 512MB RAM, 30GB HDD with View Anywhere Display (to elimi-
nate glare from overhead fluorescent lights), 12.1” wide view XGA TFT display, 
convertible keyboard, 3-M privacy filter, and Genuine Windows® XP.Patient Preference and Adherence 2009:3 325
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clock enables the accurate selection of time of medication 
and dosage (For a complete description of the database and 
interface, see Strickler and colleagues).31
Results from iterative usability testing suggest that 
the production version of the PEP-NG permits users to 
navigate with minimal errors and less “subject burden” (in 
relation to mental task load).32,33 The experience of using the 
PEP-NG did not affect BP measured immediately before and 
immediately after piloting its use. Additionally, both older 
adult users and APRNs rated the PEP-NG highly in terms of 
system usefulness and satisfaction with the program.32,33 The 
mean time for interface use by seven verification usability 
study participants (average age 82 years, range 60 to 93 years) 
was 33.08 ± 7.65 minutes.32
The PEP-NG was also evaluated with 11 older adults 
with hypertension in a time-series beta test conducted 
over a three-month period (four visits).34 The increases 
in knowledge and self-efficacy for avoiding adverse 
self-medication behaviors were statistically significant 
with large effect sizes. Behavior risk score did not change 
significantly, but the risk score was significantly correlated 
with systolic BP at visit 4. There was a significant decline 
in systolic BP (medium effect size) for the nine participants 
not at BP goal upon study entry.
The goal of the clinical trial is to reduce adverse 
self-medication practices in older adults with hypertension in 
active primary care settings through improved patient-provider 
communication about self-medication adherence and 
safety. Specific aims for older adults are to show that users 
of the PEP-NG will: 1) increase knowledge concerning 
potential adverse outcomes arising from self-medication 
practices; 2) increase self-efficacy as to how to avoid adverse 
self-medication practices; 3) reduce adverse self-medication 
behaviors; 4) improve prescription antihypertensive medica-
tion adherence; 5) achieve and maintain target blood pressure 
readings; 6) demonstrate satisfaction with the PEP-NG; and 
7) enhance the APRN provider-patient relationship. Specific 
aims for APRN providers are to show that their use of the 
PEP-NG will: 1) increase knowledge concerning potential 
adverse outcomes arising from older adults’ self-medication 
practices; 2) increase self-efficacy for teaching older 
adults about adverse self-medication practices; 3) increase 
self-efficacy for communicating with older adults about 
self-medication adherence and safety; and 4) demonstrate 
satisfaction using the PEP-NG with clients.
In summary, the PEP-NG trial will educate both patients 
with hypertension and APRN providers to improve patient 
self-medication literacy, which will result in improved 
medication adherence, reduced adverse self-medication 
behaviors, and improved BP control. As shown in Figure 1, 
increased patient self-efficacy and knowledge can increase 
patient health literacy. In addition, increased provider 
self-efficacy and conceptual knowledge will foster patient/
provider communication and patient satisfaction, resulting 
in improved listening and speaking components of patient 
health literacy.
Design, setting, and recruitment
The study has approval from the University Institutional 
Review Board (IRB) and meets all HIPAA regulations. The 
clinical trial is in cooperation with two practice-based research 
networks (PBRN) in New England. APRNet is the only 
PBRN of APRNs and is funded by the Agency for Healthcare 
Research and Quality (AHRQ) through the Yale School of 
Nursing. The Connecticut Center for Primary Care (CCPC) 
is a PBRN and an independent, not-for-profit corporation 
established under CT law by ProHealth Physicians, Inc. 
The primary care practices have widely different patient 
demographics and practice characteristics. The practices 
are located in urban centers, small cities, suburbs, and rural 
areas; while some APRNs are salaried, others are paid by the 
number of patients seen.
Primary care practice owners and APRNs affiliated with 
each PBRN were contacted by letter inviting participation 
in the study. A member of the research team met with each 
APRN who responded with interest in learning more about 
the study. The APRNs received an illustrated brochure 
describing the study and an informed consent form and 
given a demonstration of the PEP-NG software. Participating 
practices were offered free installation of a wireless access 
node (meeting HIPAA requirements)26 and a second tablet 
PC unit (in addition to the unit used for the study) as incen-
tives for participation. Practices associated with the PBRN 
networks entered the study in an ongoing basis. Ten APRNs 
in eight practice locations are enrolled in the study. Five other 
practices signed on to the study but withdrew soon after the 
installation of the wireless access nodes for reasons unrelated 
to the study (due to APRN illness, APRN job change, and 
practice location change).
Each participating APRN received a two-hour on-site 
training session with a member of the research team (who 
is a master’s prepared Registered Nurse). The APRNS 
were given a research notebook with a step-by-step study 
protocol, instruments for assessing study eligibility, record 
sheets for documenting each visit, grocery gift cards to 
compensate participants for their time, and PEP-NG study Patient Preference and Adherence 2009:3 326
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appointment cards. A supply of illustrated participant 
recruitment brochures and posters with the APRNs’ names 
and practice contact information were placed in waiting 
rooms and examination rooms.
APRNS were offered $80 to compensate for their time 
during the two-hour on-site PEP-NG training. They were also 
offered 10 continuing education units (CEUs) for reading 
10 journal articles written by the principal investigator 
(PI) (aimed at practitioners and related to potential adverse 
outcomes stemming from patients’ adverse self-medication 
behaviors) and subsequently completing the APRN pre- and 
post-training knowledge and self-efficacy surveys. APRNs 
were also offered $55 (to be paid to either the APRN or the 
practice) for each participant enrolled (up to 24 participants) 
to compensate for spending approximately 40 minutes per 
participant to: 1) ascertain study eligibility; 2) conduct the 
informed consent process; 3) cover the online tutorial with 
the patient; 4) keep receipts for participant gift cards; and 
5) file recruitment reports.
Older adults self-refer for the study by calling the practice 
and making an appointment with the APRN. The APRN 
meets with the prospective participant to review the consent 
form (written in a 14-point Arial font at a grade 6 reading 
level). Participants are requested not to participate in another 
research study related to their health while enrolled in the 
current study. If the patient consents to participate, the 
APRN then ascertains study eligibility with the following 
inclusion criteria: 1) not previously involved in a PEP study; 
2) aged at least 60 years (by self-report); 3) a health literacy 
score of at least 44 (6th grade) as measured by the Rapid 
Estimate of Adult Literacy in Medicine (REALM) tool;35,36 
4) takes prescribed antihypertensive medication; and 5) lives 
independently with independent physical and cognitive func-
tioning. The last criterion assesses patient ability to: 1) inde-
pendently manage the tasks of telephone communication, 
shopping, travel arrangements, medication taking, and 
personal finances, as assessed with the Instrumental Activities 
of Daily Living Scale;37 and 2) answer six of 10 items on the 
HEALTH LITERACY 
SELF-MEDICATION
BEHAVIOR
(OTC-Rx Use Survey) 
MEDICATION
ADHERENCE
(OTC-Rx Use Survey) 
LISTENING AND SPEAKING 
HEALTH
OUTCOMES
(BP)
PATIENT CONCEPTUAL KNOWLEDGE 
(OTC-RX Knowledge Instrument) 
READING
(REALM)
Patient Self-Efficacy
(OTC-Rx Self-Efficacy Instrument)  
Patient Satisfaction
(Satisfaction Instrument)
(Qualitative Interviews)
Provider Communication
(Communication Relationships with Providers)  
Provider Self-efficacy
(OTC-Rx Self-efficacy Instrument) 
(Eldercare Cultural Self-Efficacy Instrument)  
Provider Conceptual Knowledge
(OTC-Rx Knowledge Instrument)
Figure 1 Interplay of health literacy with project outcomes.Patient Preference and Adherence 2009:3 327
PEP-NG: Design and methodology Dovepress
submit your manuscript | www.dovepress.com
Dovepress 
Short Portable Mental Status Questionnaire.38 Participants 
also need to demonstrate a visual acuity of at least 20/100 
(with corrective lenses if needed).
The APRN selects a four-digit random number from a 
list (provided in advance by the study) as the login ID for 
each participant, another for the APRN login ID, and another 
for the site ID. The PEP-NG system randomly assigns 
participants to either the control or the intervention group. 
Patient randomization is carried out within each APRN 
practice in order to eliminate any possible confounding 
effects due to the heterogeneity among APRNs or their 
practices. APRNs mail study monitoring data monthly to 
the PI, including the numbers of patients: 1) screened for 
participation; 2) met and not met study criteria; 3) enrolled; 
4) dropped out of the study; and 5) experienced adverse or 
unexpected effects.
Interventions
APRN provider intervention
As described above, APRNs received a two-hour on-site 
training session. Before training, they logged on to a 
dedicated website to complete pre-training knowledge and 
self-efficacy instruments. As part of their on-site training, 
they logged onto the PEP-NG and proceeded through the 
program, trying out both the patient and provider interfaces. 
They were given a packet of 10 articles documenting the 
evidence that underlies the specific adverse medication 
behaviors addressed by the PEP-NG. The APRNs read these 
articles on their own time over the following two weeks and 
then logged on to the APRN PEP-NG website to complete 
post-training knowledge and self-efficacy instruments. The 
APRNs completed the post-training instruments again after 
enrollment of their 6th participant (typically three months 
later) and again after enrollment of their 12th participant 
(typically 6 months later).
Patient intervention
Each participant (from both control and intervention 
groups) meets with the APRN four times over three months 
in a private examination room at the practice site. Par-
ticipants are encouraged to bring all of their medications 
(including supplements) to each visit. At the beginning of 
visit 1, the tablet is connected to its detachable keyboard 
and the APRN records the participant’s age, gender, BP 
and health literacy score on the APRN provider screen. 
The APRN also enters each patient’s prescribed and pro-
vider recommended (eg, low-dose aspirin) medications, 
including, dose, timing, and any special instructions for 
taking the medication. The APRN then removes the tablet 
from the keyboard and sets it on a height/angle adjustable 
stand designed for study use. The APRN reads a script to 
the participant about how to use the PEP-NG while the 
participant practices using the stylus to interface with 
the tutorial program (that includes a sample question, 
a medication screen, a “clock” screen, and an interactive 
animation screen). When the participant expresses comfort 
with the PEP-NG interface, the APRN leaves the patient 
to continue with the PEP-NG to complete a demographic 
questionnaire, the knowledge and self-efficacy scales, the 
health care relationship scale as well as answer questions 
about medications they take.
On subsequent visits, before asking the patient to 
continue with the PEP-NG unassisted, the APRN reviews 
patient comfort with stylus use and the PEP-NG interface. 
The demographic questionnaire is omitted on subsequent 
visits. At the beginning of visit 4, participants complete 
the patient PEP-NG satisfaction instrument, in addition to 
the other scales and questions measured during visits 1–3. 
After each PEP-NG use, the participant meets with the 
APRN for approximately 15 minutes. The APRN takes 
the participant’s blood pressure and reviews the provider 
interface to review/update any changes in the medication 
regimen.
Participants in the intervention group receive tailored 
education. This process is triggered by the PEP-NG’s analysis 
of patient-entered data, which instantaneously generates and 
delivers intervention and education content tailored to the 
patient-reported behaviors (including the aforementioned 
“medicine facts,” animations dealing with the adverse 
behaviors identified, corrective strategies, and interactive 
questions that allow the user to apply information learned). 
A printout generated by the patient-reported data on the 
PEP-NG lists patient reported symptoms, three identified 
adverse self-medication behaviors (with the highest risk 
scores) and tailored corrective strategies suggested by the 
PEP-NG, along with a thumbnail illustration from the 
animations. In the case of fewer than three reported adverse 
behaviors, the PEP-NG delivers a set of up to three default 
statements dealing with medication adherence, OTC pain 
relievers (that can be safely taken with antihypertensives), 
and dangers of combining different types of pain relievers 
(prescription or OTC). An office assistant gives a copy of the 
printout to the patient and a second copy of the printout to 
the APRN to inform the patient visit.
Participants in the control group complete all questions 
via the PEP-NG, in addition to receiving a general education Patient Preference and Adherence 2009:3 328
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message and interactive animation as well as a question at the 
end that explains how BP medicines work and emphasizes 
how BP medications must be taken every day. Participants 
in the control group meet with the APRN for a care as usual 
BP visit without a printout.
Each participant in both groups is offered a $10 grocery 
gift card at the end of each of the first three visits and a $25 
grocery gift card at the end of the 4th visit. At the end of 
the 4th visit, the patient is provided a card with a dedicated 
telephone number to call, if they wish to schedule a 20-minute 
post-PEP-NG qualitative interview at the practice site with a 
nurse from the research team. They are then given an addi-
tional $10 grocery gift card for participating in the post-trial 
qualitative interview. Each APRN will also be interviewed 
at the end of the study to elicit their experience with the 
PEP-NG study and will be given a $25 grocery gift card to 
reimburse them for their time.
Health care utilization will be compared between the 
control and intervention groups for a cost-benefit analysis 
(CBA). A time-motion study will also be conducted. The 
total number of provider visits, emergency room visits and 
hospitalizations will be tracked for 52 weeks following the 
participant’s entry to the study. This data will be obtained 
via medical record review by the participating APRNs at 
the practice sites.
Measures
Primary and secondary outcomes
The primary outcome is patient adverse self-medication 
behavior score. BP control at each visit is a secondary 
outcome for patients. Knowledge, self-efficacy, health care 
relationships, and satisfaction with the PEP-NG are second-
ary outcomes for both patients and APRNs. Eldercare cultural 
self-efficacy is a secondary outcome for APRNs.
Baseline
The APRN records the patient’s age (confirmed from the 
medical record), gender, health literacy (using the (REALM) 
tool)35,35 and blood pressure at visit 1. All questions are 
prepared at a 6th grade Flesch–Kincaid reading level39 and 
appear on the screen in a 20-point Arial Black font. The 
patient answers demographic questions concerning liv-
ing arrangements (who they live with, type of residence), 
education, race and ethnicity, income (eg, whether their 
monthly income is above or below $1,500 per month) as 
well as health questions about current medical problems 
and symptoms. The patient then completes the self-efficacy 
and knowledge instruments. Finally, the patient responds 
to questions about what they take for hypertension and for 
common health problems.b
Blood pressure
BP measurements are taken by the APRN at each visit - at the 
beginning of PEP-NG use on visit 1 and post-PEP-NG use on 
subsequent visits. Inadequate BP control is defined as a SBP  
140 mm Hg or a DBP  90 mm Hg for patients without diabe-
tes and SBP  130 mm Hg or a DBP  80 mm Hg for patients 
with diabetes or chronic kidney disease according to the Sev-
enth Report of the Joint National Committee on Prevention, 
Detection, Evaluation, and Treatment of High Blood Pressure 
(JNC-7) guidelines.1 A potential study limitation associated 
with this protocol is that the BP measurements are taken by 
the participating APRN and could be subject to observer bias. 
Also, since patients self-refer to the study; the percentage of 
participants with controlled BP may not be representative of 
the total patient population in the practice site.
Medication use
The instrument captures self-reported, patient-entered fre-
quency and longitudinal use data on medications, supplements, 
and alcohol use. Adherence to antihypertensive medication 
is assessed from questions related to what, when, and how 
patients take their antihypertensive medication. Construct 
validity and concurrent validity of the self-report survey 
have been established in two past studies.24,25 In particular, 
concurrent validity was estimated from a survey of 25 married 
couples who completed the survey twice, once to self-report 
his or her medication use behavior and once to report his or 
her mate’s pattern of behavior. An 85% overall match rate 
across all items in each survey section was taken as supportive 
evidence of concurrent validity of self-report.40 There was no 
significant difference between the match rate for any section 
of the instrument or for the overall instrument. The high Kappa 
values (0.75) among all of the specific categories (eg, anti-
hypertensives, calcium supplements, pain relievers) provide 
further support of concurrent validity of the instrument.
Adverse self-medication behavior score 
(behavior risk score)
Following a modified Delphi method,41 data from the pilot 
test of the medication use survey were used to develop an 
b“Did you take something for ___ in the last month?” is asked with respect to 
the following problems: blood pressure, blood thinning, pain, cold or sinus, 
allergies, sleep, stomach problems such as indigestion or gas, and low thyroid. 
“Did you take ____ in the last month?” is asked with respect to: calcium pills, 
vitamins, minerals, herbs or supplements, and alcohol, wine or liquor.Patient Preference and Adherence 2009:3 329
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adverse self-medication behavior score.24 Using a five-point 
scale from 1, “very unlikely” to 5, “very likely”, a five-mem-
ber expert panel rated a list of self-medication behaviors asso-
ciated with an adverse outcome. The importance weight for 
each behavior was the mean of the expert panel ratings. The 
total score is the weighted sum of the scores for the adverse 
behaviors identified. Due to nonnormality in the distribution 
of self-medication scores in the older adult population, the 
log of the total adverse self-medication behavior score will 
be used in parametric statistical analyses.24
OTC-Rx knowledge
The knowledge instrument is modified from a previously vali-
dated 17-item instrument23–25 and based on the PEP content 
outline. Items test both knowledge and application levels in 
the cognitive domain.42 These items are short scenarios pre-
senting potential adverse medication behaviors in realistic, 
interesting settings and have one correct response and three 
distracters based upon common misconceptions about anti-
hypertensives, OTC medicines, and alcohol. The total score 
is the percent of the items that are correct. The Cronbach’s 
α reliability coefficient from testing this instrument in a 
convenience sample with 52 older adults aged over 60 years 
was 0.68, an acceptable value as naïve individuals use random 
guessing to answer knowledge items.23 Difficulty indices were 
0.25–0.75 and discrimination indices were all 0.20. The 
one-month test-retest reliability estimate was 0.50, acceptable 
for an instrument with heterogeneous content administered to 
a naïve group that uses random guessing to answer items.39 
The mean percent score obtained from these 52 older adults 
meeting study criteria at a BP clinic was 43.1 ± 15.4.23 In 
the current study, three items unrelated to hypertension (ie, 
related to warfarin) are omitted.
Preliminary data derived from administration of the same 
knowledge instrument to 31 APRN graduate student nurses 
support use with an APRN sample. The Cronbach’s α reli-
ability coefficient for this scale was 0.68 and the test–test 
reliability was 0.73. The mean percent score was 58.8 ± 13.2 
for 20 experienced registered nurses practicing in community 
health settings.43
OTC-Rx self-efficacy
The scale is based on a previously validated 13-item instru-
ment consisting of behavioral, task specific statements 
related to patient confidence in avoiding drug interactions 
arising from self-medication behaviors.23–25 The five-point 
self-report response categories range from 1, “not sure” 
to 5, “totally sure.” Responses are summed and divided by 
the number of items answered, so that the overall score is not 
affected by omitted items and is expressed in the original 
five-point metric. Previous data from 134 older adults sub-
jected to a principal factor analysis (PFA) revealed that the 
structure of the instrument was unidimensional. The single 
internal consistency estimate (Cronbach’s α) was 0.95 and 
item loadings on the single factor solution were all 0.63. 
The one-month test-retest reliability estimate for this scale 
was 0.81 (P  0.001).25 The mean score on the scale in 
the aforementioned convenience sample of 52 older adults 
attending a blood pressure clinic (who met study criteria) 
was 2.0 ± 0.8, indicating a low level of self-efficacy.23 In the 
current study, one item related to warfarin and OTC pain 
relievers is omitted.
Psychometric data were obtained with the same 31 APRN 
graduate student nurses who pilot tested the knowledge 
instrument. The self-efficacy instrument was also found to 
be a unidemensional scale with the Cronbach’s α for internal 
consistency at 0.95. The one-month test–retest reliability esti-
mate for the scale was 0.84. For 20 experienced community 
health nurses,43 the mean rating on the scale was 3.5 ± 0.8 
on the five-point scale.
Communication relationships  
with providers
The five-item instrument, based on two qualitative studies,44,45 
addresses patient–provider communication (two questions), 
trust, decision-making related to care, and satisfaction with 
care. The scale was modified for use with older adults 
by changing the visual analog 10 cm response format to 
five-point Likert-type responses with two extremes (eg, “not 
at all easy” to “very easy”).
The Cronbach’s α for the modified scale was 0.81 (from 
a sample of 121 persons aged 60 years and over) and the 
test–retest reliability estimate for the scale (generated with 
19 persons from the same sample) was r = 0.57, P = 0.014. 
Factor analysis via the principal component extraction method 
revealed one component accounting for 57% of the variance. 
All items loaded above 0.78, except for the item “How easy is it 
for you to talk with your primary care provider” which loaded 
as 0.47. From the sample of 121 persons, 90.4% reported high 
trust in their primary care provider and 86.3% felt very to com-
pletely satisfied with their care. Regarding the item “calling 
their primary care provider,” 82% felt very to completely 
comfortable and 77.5% found it was very to completely easy 
to speak with their primary care provider. In making decisions 
about their care, 79.2% reported being very to completely 
involved (Anderson et al 2009, unpublished data).Patient Preference and Adherence 2009:3 330
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Eldercare cultural self-efficacy
This five-point Likert-type scale assesses APRN self-efficacy 
in communicating with older adults about their medications. 
The scale measures nurses’ perceptions of their own confi-
dence in caring for older adults of diverse racial and ethnic 
backgrounds.46 Pilot testing of this scale with 275 senior 
student nurses revealed four principal factors following 
PFA with orthogonal rotation: 1) assessing lifestyle and 
social patterns; 2) determining cultural health practices; 
3) determining cultural beliefs; and 4) dealing with grief and 
loss. The cut-off point for retaining factor loading was above 
0.40, as recommended by Nunnally and Bernstein.40 The 
Cronbach’s α reliability coefficient for the subscales ranged 
between 0.83 and 0.92; the overall internal consistency α 
of the 28-item scale was 0.96. Average mean ratings on the 
four subscales ranged from 3.37 to 3.72. The group subscale 
mean for Factor 2: “Determining cultural health practices” 
(assessment of medication practices, use of health systems, 
dietary patterns) (seven items) was 3.52 ± 0.18 for 275 senior 
student nurses.46 The subscale mean generated from testing 
a group of 42 APRNs was 3.54 ± 0.54 and the one week 
test–retest correlation for 17 APRNs was 0.94 (Neafsey and 
Anderson 2009, unpublished data).
Satisfaction
The patient questionnaire is modified from a 14-item instru-
ment previously validated with older adults using the first 
generation PEP.24 Eight items focus on the ease of program 
use, program content, and suitability of program content and 
the other six items address the perceived likelihood of behav-
ior change following program use. The five-point Likert-type 
response format ranges from 1, “strongly disagree” to 5, 
“strongly agree.” Ratings are summed and divided by the 
number of items answered, so that the overall satisfaction 
scale is not affected by omitted items and is expressed in the 
original five-point metric. Data from a previous study of 83 
older adults using the original PEP revealed a unidimensional 
measure with a single factor accounting for 70% of the 
covariance across scale items. The Cronbach’s α estimate 
for internal consistency was 0.89.24 In the current study, an 
additional item has been added “The advice in this program 
suited my special needs” to capture satisfaction with the 
tailored education delivered.
The APRN satisfaction instrument, a five-point 
Likert-type scale, contains 10 statements regarding use of 
computer-based technology for nursing education.43 Ratings 
are summed and divided by the number of items answered, so 
that the overall satisfaction scale is not affected by omitted 
items and is expressed in the original five-point metric. When 
this instrument was applied to a previous software program 
(on drug interactions) for APRNs, the results showed a 
unidimensional scale (by PFA) with a single factor account-
ing for 68% of the variance. The Cronbach’s α for the scale’s 
internal consistency was 0.91.47
Qualitative interviews
Patient participants and APRNs choosing to be interviewed 
regarding their experience in the PEP-NG study leave a 
message on a dedicated telephone number. A member 
of the research team arranges a convenient time for the 
interview. All interviews take place at the APRN’s practice 
site. An a priori set of 15 questions (developed following 
the method of Krippenddorff    )48 is used to elicit information 
regarding what it was like to learn with the PEP-NG and 
their experience with the study. Interviews are tape-recorded 
and last between 15 minutes to one hour.
Sample size and power considerations
The study design involves three factors–ie, intervention 
(PEP-NG vs control), APRN (10 advanced practice nurses), 
and time (evaluation at baseline and at three subsequent 
time points). The design is factorial and balanced in that 
each factor is crossed with the other two factors and equal 
numbers of participants will be in each study “cell” defined 
by crossing the three factors.
When data collection is completed, the analysis plan is to 
employ repeated measures ANOVA as the basis for statistical 
testing. The primary study hypothesis concerns the possibility 
of differential change in the PEP-NG and control conditions 
between the baseline and final study assessments.
From our pilot data,25,34 we estimated that standardized 
effect sizes (d) range from 0.41 to 1.30, depending on which 
participant outcome measure was considered. Calculations 
using the smallest of these effect sizes (adverse self-medication 
risk score – the primary outcome variable) were used to deter-
mine the sample size. We believe that the pre-intervention 
mean value of the adverse self-medication risk score will be 
21.5 among participants in both the intervention and control 
groups. We expect that, with intervention, this mean score 
will decrease to 16.5 by the end of follow-up; without inter-
vention, the mean score will remain unchanged. Using data 
from the preliminary studies, we assume the standard devia-
tion of the adverse self-medication risk score will be ±10.1 
in both groups throughout follow-up. We also anticipate 
that the correlation between scores on individuals between 
the baseline and final assessments will be +0.20 or higher. Patient Preference and Adherence 2009:3 331
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Setting an objective to have 80% power to detect a difference 
in mean changes between groups, we determined a sample 
size estimate of 82 participants per group –ie, a total of 164. 
However, in order to maintain balance across all 10 APRNs, 
this estimate implied a need to recruit a minimum of 
180 participants, ie, nine per group per APRN. Anticipating 
the potential for 20% loss to follow-up among study partici-
pants, the final recruitment goal was set at 240 participants, 
ie, 12 per group per APRN, in order to have complete data 
on a sample of 180 participants. In a crossed and balanced 
design, testing results for the study’s primary hypothesis 
will be asymptotically equivalent whether performed using 
a multi-factor model or by applying a two-sample t-test to 
contrast the mean levels of within-subject changes between 
groups. The sample size estimates were derived from formulas 
related to the t-test, assumed application of one-tailed test-
ing at the 5% level of significance, and were calculated 
using PASS 2008 software (NCSS, LLC., Kaysville, UT).
A secondary outcome of special interest is blood pressure 
control. Accordingly, we also conducted power analyses 
relative to this variable to ensure that the sample size deter-
mined for the primary outcome would be sufficient to detect 
clinically meaningful differences between the intervention 
and control conditions in the maintenance or achievement 
of acceptable blood pressure levels. Based on the rates of 
hypertension control found by Chobanian and colleagues,1 
we expect to find 35% of participants with controlled blood 
pressure at the time of study entry. Due to randomization, 
the percentage of participants with controlled blood pressure 
is expected to hold, on average, in both the intervention and 
control groups. During the study period, some patients’ blood 
pressures will move into the controlled range while other 
patients’ blood pressures move out of it. We expect that, in the 
control group, at most 30% of participants will experience a 
change in blood pressure control during the study period, that 
these changes will occur in both directions with equal prob-
ability, and that, by the end of the follow-up period, 35% of 
participants will have blood pressures in the controlled range 
(though not necessarily the same persons who had controlled 
blood pressure at study entry). In the intervention group, we 
also expect that up to 30% of participants will experience a 
change in blood pressure control during the study period, but 
that these changes will occur predominantly in the direction 
from the uncontrolled range to the controlled range. Under 
these assumptions, the sample size objective of 180 partici-
pants with complete data will provide 80% power to detect a 
20% or greater increase in the percentage of participants with 
controlled blood pressure in the intervention group relative 
to the control group at the end of follow-up, ie, an expected 
frequency of 55% or more of intervention participants with 
controlled blood pressure by study completion. This power 
analysis accounted for random variation in the percent-
age of participants with controlled blood pressure at study 
entry in both the control and intervention groups (under the 
assumption of an expected frequency of 35%), for system-
atic differences and random variation in the percentages of 
participants who change blood pressure control status during 
follow-up (under the assumption of an expected frequency of 
30% or less), and for correlations due to pairing of initial and 
final blood pressure control assessments within participants. 
Determination of the variance of the test statistic was based 
on formulas from Agresti.49
Data analyses
SAS software (v. 9.2; SAS Institute, Inc., Cary, NC) will 
be used for data analysis. Both univariate (skewness and 
kurtosis coefficient) and multivariate (Mahalanobis distance) 
data screening techniques will be used. Invalid multivari-
ate outliers based on Mahalanobis distance values will be 
inspected for possible errors in coding and will be discarded 
if deemed erroneous or unrepresentative. Missing data at the 
item level will be imputed with regressed scores from avail-
able variables and the degrees of freedom in the error term 
reduced by the number of points estimated. Any case that 
has 30% or more errors will be deleted, rather than subjected 
to estimation.
Descriptive statistics will be derived by tabulating data 
recorded by the PEP-NG tracking software. Data will be ana-
lyzed as a repeated measures analysis of variance (ANOVA) 
with APRN and GROUP as between-subjects factors and 
TIME as the within-subjects factor. Because APRN can be 
considered a random factor, the appropriate analysis will be 
preceded by an assessment of the APRN × GROUP effect. 
If strong, bias in the ANOVA error terms introduced by this 
effect will be compensated by the use of quasi-F ratio tests or 
maximum likelihood techniques. Psychometric estimates for 
all instruments will be cross-validated. Cronbach’s α levels 
will be calculated for each scale and item analyses conducted 
on the knowledge scale. Standardized effect sizes will be 
calculated. Correlations between user age, education, and 
health literacy score with knowledge, self-efficacy, adverse 
self-medication behavior score, blood pressure, and satisfac-
tion scores will be assessed.
Descriptive statistics organized by race, ethnicity and 
gender will be presented. With regard to race and ethnicity, 
because the number of participants in each minority group Patient Preference and Adherence 2009:3 332
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in our catchment area is relatively small, and our sample 
reflects those small percentages, we do not have the basis 
for a statistically powerful analysis of race unless the dif-
ferences among Hispanics, Blacks, and Caucasians are very 
large and consistent. If such a situation occurs, the ANOVAs 
will incorporate race and/or ethnicity as a factor, or alterna-
tively, separate analyses will be conducted for each minority 
group. The same approach will be used if gender proves to 
be important (contrary to our expectation).
Analysis of qualitative interviews
A graduate research assistant (trained in transcription) tran-
scribes all the interviews. Krippenddorf’s content analysis 
approach will be used to guide data analysis.48 This qualita-
tive research method involves identifying, categorizing and 
labeling the patterns and themes in the data. Transcriptions 
will be reviewed and examined as part of the coding process. 
Thematic distinctions will be identified through recurring 
patterns within the data.
Cost–benefit analysis
As most of the patients enrolled in this study will have a 
number of co-morbid states, it would be difficult to determine 
whether a certain instance of health care utilization is solely 
due to inadequate/poor hypertension control. Consequently, 
the costs for any type of health care utilization, regardless 
of cause, will be included in the CBA. We will, however, 
also separately evaluate health care utilization thought to 
be related primarily to cardiac events. The total number of 
hospitalizations, emergency room and provider visits will 
be tracked for 52 weeks following study entry via queries 
of claims and billing databases and supplemented through 
medical record review by the APRN.
The cost of health care resources will be valued using 
Medicare reimbursment rates as described by Tumeh and 
colleagues.50 Prospective payment system coding for inpa-
tient and outpatient services (utilizing diagnosis-related 
group [DRG] and Ambulatory Payment Classification [APC] 
codes) and the Medicare Physician Fee Schedule (utilizing 
the Health Common Procedure Coding System [HCPCS]/
Current Procedural Terminology [CPT] codes) will be used 
to assign costs to hospitalizations, emergency room and 
provider office visits. A time-motion study will be conducted 
to determine APRN time required to obtain medical history 
information and complete the APRN visit in the presence 
(tailored) or absence (routine) of the PEP-NG.51,52 For both 
control and intervention groups, three to five observations 
will be made on at least three separate occasions. The APRN 
will record time to the nearest minute and will be based on 
activities required to collect and organize medical history 
data for an individual patient. The cost of personnel will be 
estimated by multiplying mean time spent by the average 
hourly wage rate.53 Due to the short-term nature of the study, 
discounting will not be performed.54 Costs will be adjusted 
to 2008 US dollars using the Consumer Price Index for 
Medical Care.55
Threshold (TSA) and probabilistic sensitivity analyses 
(Monte Carlo simulation) will be conducted to test the 
robustness of the results and conclusions of our cost-benefit 
analysis.51 The PEP-NG acquisition cost, personnel time and 
wage rate will be varied in the sensitivity analyses. For the 
TSA, if the tested variables do not vary outside the range 
of plausible values, confidence in the study results will be 
strengthened. For the Monte Carlo simulation, the acquisi-
tion cost of the PEP-NG will be varied by 50%, personnel 
time will be varied ±1 standard deviation, and wage rate will 
be varied using the minimum and maximum wage rate for 
APRNs employed in the United States.51,53
Discussion
The study described herein is an effectiveness trial in the 
“realistic setting” of 10 primary care practices. Partici-
pants self-refer to the study and may not reflect the general 
population of patients in the practice with respect to either 
demographic characteristics or degree of adherence to their 
antihypertensive regimen. While this aspect of the design 
will limit generalizability, we will derive findings as to the 
feasibility and cost/benefit of the intervention, as well as 
patient and provider satisfaction.
Gehi and colleagues56 found that the cardiovascular risk 
associated with self-reported nonadherence (ie, answering 
a single survey question, “In the last month, how often did 
you take your medications as your doctor prescribed?”) was 
as great as that from smoking or diabetes. While the simple 
self-report approach taken by the PEP-NG may underestimate 
adherence, it does identify nonadherence and may foster a 
subsequent discussion between patient and provider about the 
reasons for nonadherence as well as strategies for improved 
adherence to the medication regimen.
The risk of potential adverse drug interactions (PADI) 
is greatly increased in older adults having three or more 
chronic diseases, five or more medications per day, more than 
12 medication doses taken per day, a history of nonadherence, 
or a drug requiring therapeutic monitoring.57 In a primary care 
environment where the median time of a visit is 14 minutes,58 
the PEP-NG can use patient “waiting room time” to identify Patient Preference and Adherence 2009:3 333
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those patients with PADIs and deliver education tailored to 
the patient’s specific medication behaviors. The PEP-NG has 
the potential to allow providers to redirect time during the 
visit to answer patient questions and engage in patient teach-
ing instead of querying patients about medication behaviors 
and looking up drug interaction information.
Conclusion
The PEP-NG is a self-directed computer-mediated communi-
cation program that provides a means for patients to become 
aware of their own adverse medication behaviors and learn to 
modify behavior for improving their own health. It empowers 
older adults with hypertension with a self-management 
mechanism that enables them to enhance their self-efficacy in 
self care, which is the corner stone of improving public health. 
The PEP-NG offers the provider advance knowledge of a 
patient’s self-medication behavior and literacy, which can be 
instrumental in facilitating patient–provider communication 
aimed at improving medication adherence and safety. If found 
effective in the current clinical trial, the PEP-NG has the 
potential for rapid adoption in the primary care setting and 
become a model for other self-management and medication 
adherence interventions directed at other serious chronic 
conditions (eg, diabetes, asthma, etc) that pose the major 
threats to public health.
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